These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3450719)

  • 1. [Tumor markers in cancer of the ovary].
    Ritter J
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(8):1086-7. PubMed ID: 3450719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers and ovarian cysts].
    Vinatier D; Houfflin V; Collinet P
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S34-40. PubMed ID: 11917374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the ovary.
    Liu CM
    N Engl J Med; 2005 Mar; 352(12):1268-9; author reply 1268-9. PubMed ID: 15791705
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor markers and ovarian cancer].
    Trifonov I; Todorova M
    Akush Ginekol (Sofiia); 2002; 41 Suppl 1():7-11. PubMed ID: 12412346
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor markers in malignant ovarian tumors].
    Kudela M; Fingerová H; Gebauer T
    Cesk Gynekol; 1991 Nov; 56(5-6):355-60. PubMed ID: 1815843
    [No Abstract]   [Full Text] [Related]  

  • 7. [CA 125 in epithelial ovarian cancer].
    Mogensen O
    Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apolipoprotein E immunoreactivities in normal human ovary and ovarian neoplasms].
    Umemori Y; Chiba H; Tokusashi Y; Miyokawa N
    Rinsho Byori; 1998 Jan; 46(1):69-72. PubMed ID: 9492541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular markers of ovarian carcinoma].
    Dobryszycka W
    Postepy Hig Med Dosw; 2000; 54(4):495-518. PubMed ID: 11016269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of test positive predictive value in ovarian cancer screening.
    Greene MH; Feng Z; Gail MH
    Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
    [No Abstract]   [Full Text] [Related]  

  • 11. A review and an update on the screening of epithelial ovarian cancer.
    Reynolds EA; Moller KA
    Curr Probl Cancer; 2006; 30(5):203-32. PubMed ID: 16996383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of tumor markers for the diagnosis of ovarian carcinoma].
    Serdev V; Mateeva E; Ankov V; Mikhaĭlova-Todorova S; Ivanova I
    Akush Ginekol (Sofiia); 1987; 26(4):60-4. PubMed ID: 3674327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumour markers in epithelial ovarian cancer].
    Sparholt MH; Høgdall E; Høgdall CK
    Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
    Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
    Tang BJ; Li L; Xu J
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management?
    Narod S
    Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for ovarian cancer-risk, education, worry: path to appropriate use?
    Skates SJ
    Gynecol Oncol; 2002 Apr; 85(1):1-2. PubMed ID: 11925112
    [No Abstract]   [Full Text] [Related]  

  • 18. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
    De Smet F; Pochet NL; De Moor BL; Van Gorp T; Timmerman D; Vergote IB; Hartmann LC; Damokosh AI; Hoersch S
    Clin Cancer Res; 2005 Nov; 11(21):7958-9; author reply 7959. PubMed ID: 16278422
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems for tumor markers in gynecological malignancies].
    Li GT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):2-4. PubMed ID: 18366922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.